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ABSTRACT
The occurrence of a solitary sternal metastasis from
breast cancer is relatively uncommon, and its treat-
ment is controversial. Most case reports on the role of
sternal resection in what is termed a “solitary sternal
metastasis” tend to present a rather optimistic outcome.
Here, we report the case of a premenopausal
woman with axillary lymph node–positive, triple-nega-
tive breast cancer treated with mastectomy followed
by adjuvant chemotherapy and radiation therapy. She
developed a radiologically isolated sternal recurrence
3 years later, which was treated with partial
sternectomy. The present case report reviews the use
of sternectomy for breast cancer recurrence and high-
lights the need for thorough clinical and radiologic
evaluation to ensure the absence of other systemic dis-
ease before extensive surgery is undertaken.
KEY WORDS
Breast cancer, sternal metastasis, sternectomy
1. CASE REPORT
A 35-year-old woman with a history of breast cancer
diagnosed 3 years earlier was referred to us for dis-
cussion of bisphosphonate use after surgical excision
of an isolated sternal metastasis. Her initial breast can-
cer was treated with left mastectomy and axillary node
dissection. Pathology revealed multifocal, poorly-dif-
ferentiated invasive ductal carcinoma with three tu-
mour masses (2.3 cm, 2.0 cm, and 1.1 cm). Of 14 lymph
nodes, 5 were involved. Margins were negative. Im-
munohistochemistry was negative for estrogen, proges-
terone, and human epidermal growth factor (HER2/neu)
receptors. This patient received adjuvant epirubicin/5-
fluorouracil/cyclophosphamide (FEC-100) chemo-
therapy for 6 cycles and locoregional radiation
treatment. Subsequently, she also had a prophylactic
contralateral mastectomy and bilateral transrectus ab-
dominal muscle flap reconstructions. Genetic testing
was negative for BRCA1 and BRCA2 mutations.
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Three years after completion of adjuvant systemic
therapy, this woman presented to her family physician
with new-onset chest and neck tenderness during preg-
nancy. Investigations were deferred for 6 months until
she was postpartum. A computed tomography scan of
the neck and chest revealed a 5-cm soft-tissue mass
with manubrial destruction consistent with recurrent
disease (Figure 1). Restaging revealed no other foci of
metastatic disease, and a bone scan showed uptake
only in the manubrium. Given the clinical and radio-
logic impression of an isolated focus of recurrence,
the patient elected to have a partial sternectomy.
Pathology revealed a 5.4-cm, poorly differentiated
invasive ductal carcinoma infiltrating the manubrium
FIGURE 1 Computed tomography of the thorax, performed
preoperatively, shows a soft-tissue mass with manubrial destruction
(arrows). (A) Soft-tissue window. (B) Bone window.
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with involvement of the left sternocleidomastoid muscle
and left clavicular head. Three lymph nodes were posi-
tive (one sternocleidomastoid and two thymic). Mar-
gins were clear. Once again, immunohistochemistry
was triple-negative.
There were no postoperative complications, and
after a 6-week recovery, the woman was referred to our
team for a second opinion regarding bisphosphonate use
following surgical excision of the sternal metastasis. At
presentation, she was asymptomatic. On physical ex-
amination, the scars from her breast reconstructions and
sternal surgery were evident. She also had two palpable
0.5-cm right supraclavicular nodes.
Restaging radiologic imaging performed 6 weeks
after her surgery confirmed sub-centimetre right su-
praclavicular lymph nodes and also an enlarged 1.6-cm
left supraclavicular lymph node (Figure 2). Fine-needle
aspiration of the latter node was positive for triple-nega-
tive, poorly differentiated invasive ductal carcinoma.
2. DISCUSSION
In patients with breast cancer, the presence of either
sternal involvement or an isolated sternal metastasis
is relatively uncommon, with reported incidences of
5.2% and 1.9%–2.4% respectively 1,2. Sternal involve-
ment may occur either from direct invasion by enlarged
internal mammary lymph nodes or from hematogenous
spread. However, in contrast with vertebral lesions,
which tend to result in multicentric bony disease from
spread through the paravertebral plexus 3, some ster-
nal lesions have been observed to remain solitary with
time and may be amenable to surgical resection with
curative intent 4,5.
Sternectomy for isolated breast cancer recurrence
remains a controversial issue, and the literature con-
sists predominantly of retrospective case series.
Noguchi et al. 6 performed sternal resections with
parasternal and mediastinal lymph node dissection on
9 patients before chemo-endocrine therapy. Eventual
relapse in 8 patients revealed that lymph node dissec-
tion had no effect on locoregional control. Neverthe-
less, the dissection provided prognostic information,
because all patients with involved parasternal and
mediastinal lymph nodes relapsed and died within 30
months, but 3 patients without lymph node involvement
survived for more than 6 years.
Lequaglie et al. 7 performed radical, curative-in-
tent sternectomies in a subgroup of 28 patients with
isolated breast cancer recurrence and found that the
10-year overall survival in the group was 41.8%. These
authors suggested that sternectomy could be curative
in carefully selected patients.
An isolated sternal metastasis should, however, be
regarded with caution, because it is more likely to her-
ald systemic disease than to be truly solitary. Kwai et
al. 1 demonstrated that 54% of patients with breast can-
cer and solitary sternal metastasis developed other foci
of distant disease within 20 months. The predominance
of pulmonary metastasis and distant skeletal disease
found is their study was attributed to drainage of the
internal mammary nodes into the subclavian vein.
Consequently, patients with breast cancer present-
ing with a solitary sternal metastasis require thorough
restaging evaluation to rule out other foci of metastatic
disease. Treatment should be based on a multimodality
approach. With an isolated recurrence, local therapy
with radiation would be appropriate. In the presence of
distant disease, systemic options should be offered.
Surgical resection should be reserved for palliation or
for instances in which the other treatment modalities
are not possible.
Furthermore, the natural history of the initial breast
cancer and the prognosis following recurrence should
be considered. An important aspect of the present case
is that our patient had a triple-negative breast cancer
with axillary node involvement. Compared with other
breast cancers, this disease subtype is highly aggres-
sive, with an increased rate of early development of
distant recurrence that peaks at 3 years after diagno-
sis 8. Progression is rapid, with a median survival of
only 9 months following recurrence. In addition, the
extensive literature on relapsed breast cancer demon-
strates that a shorter disease-free interval from time of
initial treatment is associated with worse prognosis 9.
3. CONCLUSIONS
Although resection of a so-called isolated sternal me-
tastasis is surgically feasible, it should be assessed and
discussed with patients on a case-by-case basis. In the
case of our patient, her history of a treated lymph node–
positive tumour with triple-negative phenotype and re-
currence within 3 years following mastectomy,
chemotherapy, and radiotherapy should realistically have
predicted this tragic outcome of widespread relapse
within weeks following her extensive palliative surgery.
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